← Back to Clinical Trials
Recruiting NCT07203612

NCT07203612 Tailoring a Home Supervision Intervention for Latinx Caregivers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07203612
Status Recruiting
Phase
Sponsor Western Michigan University
Condition Healthy
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2024-05-09
Primary Completion 2026-07-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 99 Years
Study Type INTERVENTIONAL
Interventions
SHSParenting group

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2024-05-09 with a primary completion date of 2026-07-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the proposed study is to create and test a modified version of the SHS intervention for Latinx families in Southwest Michigan. We will partner with three nearby Latinx resource centers in addition to a Head Start program that provides preschool to a large number of Latinx families. The project will use an iterative approach to modifying the intervention and will occur in five steps. In step 1, we will conduct focus groups with caregivers and staff from the 3 Latinx resource centers to identify changes to make to the intervention materials. In step 2, we will make modifications to the program materials. In step 3, we will conduct additional focus groups to seek feedback about the revised program materials. In step 4, we will pilot test the revised program materials, and in step 5 we will conduct the RCT of the modified program materials with caregivers of children ages 2-5. We will examine the effect of the modified intervention on caregivers' supervision of their children (using self-reports and observations) and on children's minor injury frequency.

Eligibility Criteria

Inclusion Criteria: * Spanish speaking caregiver of child ages 15 months to 5 years old. Exclusion Criteria: * child of caregiver has pervasive develomental disorder, is blink, or deaf.

Contact & Investigator

Central Contact

Amy Damashek, Ph.D.

✉ Amy.Damashek@wmich.edu

📞 269-387-4920

Principal Investigator

Amy Damashek, Ph.D.

PRINCIPAL INVESTIGATOR

Western Michigan University

Frequently Asked Questions

Who can join the NCT07203612 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Healthy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07203612 currently recruiting?

Yes, NCT07203612 is actively recruiting participants. Contact the research team at Amy.Damashek@wmich.edu for enrollment information.

Where is the NCT07203612 trial being conducted?

This trial is being conducted at Kalamazoo, United States.

Who is sponsoring the NCT07203612 clinical trial?

NCT07203612 is sponsored by Western Michigan University. The principal investigator is Amy Damashek, Ph.D. at Western Michigan University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology